Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Genetic Predisposition

etoposide has been researched along with Genetic Predisposition in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.26)18.2507
2000's7 (36.84)29.6817
2010's11 (57.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Annala, M; Beltran, H; Chedgy, EC; Chi, KN; Donoghue, AJ; Fazli, L; Herberts, C; Hurtado-Coll, A; Konomura, S; Liew, J; Parimi, S; Ritch, E; Sboner, A; Sigouros, M; Struss, W; Vandekerkhove, G; Vergidis, J; Wyatt, AW1
Barroilhet, L; Buza, N; Hui, P; McGregor, SM; Zheng, X1
Chen, X; Li, W; Ma, KW; Wang, X; Wang, YZ1
Chang, J; Du, Z; Li, D; Lin, D; Shen, H; Tan, W; Wei, L; Wu, C; Wu, T; Xu, B; Yu, D; Yuan, P1
Andrake, MD; Arora, S; Bodian, DL; Daly, MB; Dunbrack, RL; Egleston, BL; Giri, VN; Golemis, EA; Hall, MJ; Handorf, ED; Nicolas, E; Ross, EA; Serebriiskii, IG; Vockley, JG; Zhou, Y1
Narendran, V; Pandian, AJ; Shah, PK; Sripriya, S1
Beltrão, EI; Benicio, MT; Bezerra, MA; Bezerra, MF; Coelho-Silva, JL; Lucena-Araujo, AR; Machado, CG; Nascimento, JC; Rego, EM; Rocha, CR1
Borg, C; Deconinck, E; Guenat, D; Merla, G; Rohrlich, PS1
Fang, JH; Jiang, W; Liang, C; Qiu, FE; Shen, Y; Xiong, XD; Zhuang, SM1
Ishii, E1
Guan, Y; Lin, D; Liu, Y; Miao, X; Shen, H; Wu, C; Wu, T; Xu, B; Xu, J; Yu, D; Yuan, P; Zhang, T1
Cox, NJ; Dolan, ME; Gamazon, ER; Huang, RS1
Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT1
Allen, SL; Archer, KJ; Baldus, CD; Bloomfield, CD; Caligiuri, MA; Carroll, AJ; de la Chapelle, A; Kolitz, JE; Larson, RA; Marcucci, G; Moore, JO; Powell, BL; Ruppert, AS; Tanner, SM; Vardiman, JW; Whitman, SP1
Atienza, JM; Denissenko, MF; Ekblom, J; Kammerer, S; Rehbock, J; Rosette, C; Roth, RB; Smylie, KJ1
Artac, H; Caliskan, U; Ilerisoy-Yakut, Z; Koksal, Y; Reisli, I; Ucar, C; Yurtcu, M1
Cordone, I; De Cuia, R; Fenu, S; Guerrisi, V; Mandelli, F; Mauro, FR; Meloni, G; Pescarmona, E; Proia, A; Reato, G1
Greco, FA; Hainsworth, JD1
Horie, H; Kinugawa, N; Kudoh, F; Miyamoto, S; Okimoto, Y; Oto, S1

Reviews

3 review(s) available for etoposide and Genetic Predisposition

ArticleYear
[Progress in the molecular analysis of infant leukemias].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:10

    Topics: Enzyme Inhibitors; Etoposide; Female; Gene Rearrangement; Genetic Predisposition to Disease; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia, Myeloid, Acute; Male; Maternal Exposure; MicroRNAs; Myeloid-Lymphoid Leukemia Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Topoisomerase II Inhibitors

2009
Dysgerminoma in a child with ataxia-telangiectasia.
    Pediatric hematology and oncology, 2007, Volume: 24, Issue:6

    Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia; Biomarkers, Tumor; Bleomycin; CA-125 Antigen; Carboplatin; Child; Chorionic Gonadotropin, beta Subunit, Human; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Immunoglobulins, Intravenous; Neoplasm Proteins; Ovarian Neoplasms; Ovariectomy; Respiration Disorders

2007
Germ cell neoplasms and other malignancies of the mediastinum.
    Cancer treatment and research, 2001, Volume: 105

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Carcinoma; Child; Cisplatin; Combined Modality Therapy; Etoposide; Genetic Predisposition to Disease; Germinoma; Hematologic Neoplasms; Humans; Incidence; Klinefelter Syndrome; Lymphoma, Non-Hodgkin; Mediastinal Neoplasms; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Nerve Tissue; Radiotherapy, Adjuvant; Seminoma; Treatment Outcome

2001

Trials

2 trial(s) available for etoposide and Genetic Predisposition

ArticleYear
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:3

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2012
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.
    Blood, 2003, Sep-01, Volume: 102, Issue:5

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Genetic Markers; Genetic Predisposition to Disease; Humans; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Predictive Value of Tests; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Treatment Outcome

2003

Other Studies

14 other study(ies) available for etoposide and Genetic Predisposition

ArticleYear
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma.
    The Journal of pathology, 2018, Volume: 246, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Small Cell; Cisplatin; Databases, Factual; DNA Repair; Etoposide; Gene Expression Profiling; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Genomic Instability; Humans; Male; Middle Aged; Neoplasms, Complex and Mixed; Phenotype; Prostatic Neoplasms; Retrospective Studies; Time Factors; Treatment Outcome

2018
Paternal uniparental isodisomy of tyrosine hydroxylase locus at chromosome 11p15.4: spectrum of phenotypical presentations simulating hydatidiform moles.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2019, Volume: 32, Issue:8

    Topics: Abortion, Missed; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosomes, Human, Pair 11; Cyclophosphamide; Dactinomycin; Etoposide; Female; Genetic Loci; Genetic Predisposition to Disease; Humans; Hydatidiform Mole; Male; Methotrexate; Phenotype; Pregnancy; Treatment Outcome; Tyrosine 3-Monooxygenase; Uniparental Disomy; Uterine Neoplasms; Vincristine

2019
MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients.
    Oncology research and treatment, 2014, Volume: 37, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; China; Cisplatin; Etoposide; Female; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neutropenia; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-mdm2; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome; Tumor Suppressor Protein p53

2014
Association of GWAS-identified lung cancer susceptibility loci with survival length in patients with small-cell lung cancer treated with platinum-based chemotherapy.
    PloS one, 2014, Volume: 9, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Chromosomes, Human, Pair 20; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 5; Etoposide; Female; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Lung Neoplasms; Male; Middle Aged; Polymorphism, Single Nucleotide; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome

2014
Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer.
    Oncotarget, 2015, Nov-24, Volume: 6, Issue:37

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Cells, Cultured; DNA Breaks, Double-Stranded; DNA Repair; Etoposide; Exome; Family Health; Genetic Predisposition to Disease; Histones; Humans; INDEL Mutation; Male; Middle Aged; Mutation; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Assessment; Risk Factors; Sequence Analysis, DNA; T-Lymphocytes

2015
Prenatal genetic diagnosis of retinoblastoma and report of RB1 gene mutation from India.
    Ophthalmic genetics, 2016, Volume: 37, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; DNA Mutational Analysis; Etoposide; Exons; Female; Genes, Retinoblastoma; Genetic Predisposition to Disease; Genetic Testing; Germ-Line Mutation; Humans; India; Infant; Pedigree; Prenatal Diagnosis; Proton Therapy; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Binding Proteins; Ubiquitin-Protein Ligases; Vincristine

2016
Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.
    Haematologica, 2017, Volume: 102, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Etoposide; Female; Gene Expression; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Survival Analysis; Thioguanine; Tumor Suppressor Protein p53

2017
DNA damage response defect in Williams-Beuren syndrome.
    International journal of molecular medicine, 2017, Volume: 39, Issue:3

    Topics: Case-Control Studies; Cell Cycle; Cell Line; Cell Proliferation; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Gene Knockdown Techniques; Gene Silencing; Genetic Predisposition to Disease; Histones; Humans; Hydroxyurea; RNA, Small Interfering; Williams Syndrome

2017
Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma.
    Mutation research, 2009, Mar-09, Volume: 662, Issue:1-2

    Topics: Adult; Aged; Apoptosis; Carcinoma, Hepatocellular; Case-Control Studies; Cell Cycle Proteins; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nuclear Proteins; Nucleic Acid Conformation; Polymorphism, Single Nucleotide; RNA, Messenger

2009
Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients.
    Cancer research, 2010, Dec-01, Volume: 70, Issue:23

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cohort Studies; Etoposide; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genotype; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Phosphoproteins; Polymorphism, Single Nucleotide; Prognosis; Promoter Regions, Genetic; Transcription Factors; YAP-Signaling Proteins

2010
Copy number polymorphisms and anticancer pharmacogenomics.
    Genome biology, 2011, Volume: 12, Issue:5

    Topics: Antineoplastic Agents; Biomarkers, Pharmacological; Carboplatin; Cell Line, Tumor; Cisplatin; Daunorubicin; Etoposide; Gene Dosage; Gene Expression; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genome, Human; Humans; Inhibitory Concentration 50; Neoplasms; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Topoisomerase II Inhibitors

2011
Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:3

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Bleomycin; Breast; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Genome; Humans; Neoplasms; Nuclear Proteins; Phosphoproteins; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Time Factors; Transfection

2005
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:11

    Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Fatal Outcome; Genetic Predisposition to Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lung Neoplasms; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Recombinant Proteins; Risk; Smoking; Transplantation Conditioning; Transplantation, Autologous; Vidarabine

2000
Treatment for B-cell-type lymphoma in a girl associated with Bloom's syndrome.
    Clinical genetics, 1992, Volume: 41, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bloom Syndrome; Child; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Etoposide; Female; Genetic Predisposition to Disease; Humans; Hydrocortisone; Lymphoma, B-Cell; Methotrexate; Pharyngeal Neoplasms; Prednisolone; Prognosis; Remission Induction

1992